Please enable JavaScript to continue using this application.

Compare tickers

Valuation, margins, and growth side by side.

Compare $JNJ vs $RPRX | Chartloom

Compare

$JNJ vs $RPRX

Johnson & Johnson · Royalty Pharma PLC

JNJ

Johnson & Johnson

RPRX

Royalty Pharma PLC

Compare $JNJ vs $RPRX

Comparing Johnson & Johnson and Royalty Pharma PLC

JNJJohnson & Johnson

RPRXRoyalty Pharma PLC

JNJJohnson & Johnson

Market cap

$599.13B

P/E (TTM)

36.04x

Forward P/E (NTM)

20.15x

Forward P/S (NTM)

5.60x

Rev growth (TTM)

7.8%

YTD performance

19.9%

52W performance

30.4%

FCF yield

2.4%

RPRXRoyalty Pharma PLC

Market cap

$32.57B

P/E (TTM)

38.65x

Forward P/E (NTM)

11.88x

Forward P/S (NTM)

9.72x

Rev growth (TTM)

10.0%

YTD performance

45.6%

52W performance

57.1%

FCF yield

1.8%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

JNJ

RPRX

Detailed metrics comparison

JNJ

Johnson & Johnson

RPRX

Royalty Pharma PLC

Market Cap

JNJ$599.13B

RPRX$32.57B

Enterprise Value

JNJ$599.13B

RPRX$40.72B

Price

JNJ$248.61

RPRX$56.57

P/E Ratio

JNJ36.04x

RPRX38.65x

P/S Ratio

JNJ6.03x

RPRX12.84x

EV/Sales

JNJ6.03x

RPRX16.06x

EV/EBITDA

JNJ23.12x

RPRX25.19x

P/B Ratio

JNJ7.41x

RPRX4.79x

P/FCF Ratio

JNJ42.10x

RPRX56.41x

EV/FCF

JNJ42.10x

RPRX70.52x

PEG Ratio

JNJ3.44x

RPRX3.89x

Forward P/E (NTM)

JNJ20.15x

RPRX11.88x

Forward P/S (NTM)

JNJ5.60x

RPRX9.72x

Revenue (TTM)

JNJ$99.34B

RPRX$2.54B

Revenue Growth (YoY)

JNJ7.8%

RPRX10.0%

Forward Rev Growth

JNJ7.3%

RPRX5.2%

Gross Margin (TTM)

JNJ67.7%

RPRX0.0%

Operating Margin (TTM)

JNJ25.7%

RPRX59.6%

EBITDA Margin (TTM)

JNJ26.1%

RPRX62.3%

Net Margin (TTM)

JNJ16.2%

RPRX32.1%

FCF Margin (TTM)

JNJ14.3%

RPRX22.8%

Net Income (TTM)

JNJ$16.10B

RPRX$815M

FCF (TTM)

JNJ$14.23B

RPRX$578M

EPS (TTM)

JNJ$6.90

RPRX$1.46

ROE (TTM)

JNJ25.7%

RPRX12.3%

ROA (TTM)

JNJ10.6%

RPRX4.2%

ROIC (TTM)

JNJ16.0%

RPRX5.2%

Cash

JNJ$0

RPRX$812M

Debt

JNJ$0

RPRX$8.96B

Net Cash/Debt

JNJ$0

RPRX$-8.15B

Current Ratio (TTM)

JNJ1.09x

RPRX2.80x

Quick Ratio (TTM)

JNJ0.73x

RPRX2.80x

Debt/Equity (TTM)

JNJ0.58x

RPRX1.31x

Debt/Assets (TTM)

JNJ0.0%

RPRX0.0%

Interest Coverage (TTM)

JNJN/A

RPRXN/A

Net Debt/EBITDA (TTM)

JNJ0.00x

RPRX0.00x

Beta

JNJ0.20

RPRX0.39

52W Performance

JNJ30.4%

RPRX57.1%

YTD Performance

JNJ19.9%

RPRX45.6%

% from 52W High

JNJ-11.5%

RPRX-12.1%

% from 52W Low

JNJ34.6%

RPRX60.6%

Asset Turnover (TTM)

JNJ0.49x

RPRX0.13x

FCF Yield (TTM)

JNJ2.4%

RPRX1.8%

Earnings Yield (TTM)

JNJ2.7%

RPRX2.5%

Dividend Yield (TTM)

JNJ2.0%

RPRX1.2%

Rule of 40

JNJ22.1

RPRX32.8

EV/GP/RG

JNJ1.15

RPRXN/A

Ticker research

View JNJ research View RPRX research

Metric	JNJ Johnson & Johnson	RPRX Royalty Pharma PLC
Market & Valuation
Market Cap	$599.13B	$32.57B
Enterprise Value	$599.13B	$40.72B
Price	$248.61	$56.57
P/E Ratio	36.04x	38.65x
P/S Ratio	6.03x	12.84x
EV/Sales	6.03x	16.06x
EV/EBITDA	23.12x	25.19x
P/B Ratio	7.41x	4.79x
P/FCF Ratio	42.10x	56.41x
EV/FCF	42.10x	70.52x
PEG Ratio	3.44x	3.89x
Forward P/E (NTM)	20.15x	11.88x
Forward P/S (NTM)	5.60x	9.72x
Revenue & Growth
Revenue (TTM)	$99.34B	$2.54B
Revenue Growth (YoY)	7.8%	10.0%
Forward Rev Growth	7.3%	5.2%
Profitability
Gross Margin (TTM)	67.7%	0.0%
Operating Margin (TTM)	25.7%	59.6%
EBITDA Margin (TTM)	26.1%	62.3%
Net Margin (TTM)	16.2%	32.1%
FCF Margin (TTM)	14.3%	22.8%
Net Income (TTM)	$16.10B	$815M
FCF (TTM)	$14.23B	$578M
EPS (TTM)	$6.90	$1.46
ROE (TTM)	25.7%	12.3%
ROA (TTM)	10.6%	4.2%
ROIC (TTM)	16.0%	5.2%
Financial Health
Cash	$0	$812M
Debt	$0	$8.96B
Net Cash/Debt	$0	$-8.15B
Current Ratio (TTM)	1.09x	2.80x
Quick Ratio (TTM)	0.73x	2.80x
Debt/Equity (TTM)	0.58x	1.31x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.20	0.39
52W Performance	30.4%	57.1%
YTD Performance	19.9%	45.6%
% from 52W High	-11.5%	-12.1%
% from 52W Low	34.6%	60.6%
Efficiency & Yields
Asset Turnover (TTM)	0.49x	0.13x
FCF Yield (TTM)	2.4%	1.8%
Earnings Yield (TTM)	2.7%	2.5%
Dividend Yield (TTM)	2.0%	1.2%
Other
Rule of 40	22.1	32.8
EV/GP/RG	1.15	N/A
Ticker research	View JNJ research	View RPRX research

Valuation

P/E Ratio

JNJ

36.04x

RPRX

38.65x

P/S Ratio

JNJ

6.03x

RPRX

12.84x

EV/FCF

JNJ

42.10x

RPRX

70.52x

Growth & revenue

Revenue Growth TTM

RPRX

10.0%

JNJ

7.8%

Forward Revenue Growth

JNJ

7.3%

RPRX

5.2%

Profitability & performance

Gross Margin

JNJ

67.7%

RPRX

0.0%

ROE

JNJ

25.7%

RPRX

12.3%

FCF Yield %

JNJ

2.4%

RPRX

1.8%

52-Week Performance

RPRX

57.1%

JNJ

30.4%

Detailed metrics comparison

JNJ

Johnson & Johnson

RPRX

Royalty Pharma PLC

Market Cap

JNJ$599.13B

RPRX$32.57B

Enterprise Value

JNJ$599.13B

RPRX$40.72B

Price

JNJ$248.61

RPRX$56.57

P/E Ratio

JNJ36.04x

RPRX38.65x

P/S Ratio

JNJ6.03x

RPRX12.84x

EV/Sales

JNJ6.03x

RPRX16.06x

EV/EBITDA

JNJ23.12x

RPRX25.19x

P/B Ratio

JNJ7.41x

RPRX4.79x

P/FCF Ratio

JNJ42.10x

RPRX56.41x

EV/FCF

JNJ42.10x

RPRX70.52x

PEG Ratio

JNJ3.44x

RPRX3.89x

Forward P/E (NTM)

JNJ20.15x

RPRX11.88x

Forward P/S (NTM)

JNJ5.60x

RPRX9.72x

Revenue (TTM)

JNJ$99.34B

RPRX$2.54B

Revenue Growth (YoY)

JNJ7.8%

RPRX10.0%

Forward Rev Growth

JNJ7.3%

RPRX5.2%

Gross Margin (TTM)

JNJ67.7%

RPRX0.0%

Operating Margin (TTM)

JNJ25.7%

RPRX59.6%

EBITDA Margin (TTM)

JNJ26.1%

RPRX62.3%

Net Margin (TTM)

JNJ16.2%

RPRX32.1%

FCF Margin (TTM)

JNJ14.3%

RPRX22.8%

Net Income (TTM)

JNJ$16.10B

RPRX$815M

FCF (TTM)

JNJ$14.23B

RPRX$578M

EPS (TTM)

JNJ$6.90

RPRX$1.46

ROE (TTM)

JNJ25.7%

RPRX12.3%

ROA (TTM)

JNJ10.6%

RPRX4.2%

ROIC (TTM)

JNJ16.0%

RPRX5.2%

Cash

JNJ$0

RPRX$812M

Debt

JNJ$0

RPRX$8.96B

Net Cash/Debt

JNJ$0

RPRX$-8.15B

Current Ratio (TTM)

JNJ1.09x

RPRX2.80x

Quick Ratio (TTM)

JNJ0.73x

RPRX2.80x

Debt/Equity (TTM)

JNJ0.58x

RPRX1.31x

Debt/Assets (TTM)

JNJ0.0%

RPRX0.0%

Interest Coverage (TTM)

JNJN/A

RPRXN/A

Net Debt/EBITDA (TTM)

JNJ0.00x

RPRX0.00x

Beta

JNJ0.20

RPRX0.39

52W Performance

JNJ30.4%

RPRX57.1%

YTD Performance

JNJ19.9%

RPRX45.6%

% from 52W High

JNJ-11.5%

RPRX-12.1%

% from 52W Low

JNJ34.6%

RPRX60.6%

Asset Turnover (TTM)

JNJ0.49x

RPRX0.13x

FCF Yield (TTM)

JNJ2.4%

RPRX1.8%

Earnings Yield (TTM)

JNJ2.7%

RPRX2.5%

Dividend Yield (TTM)

JNJ2.0%

RPRX1.2%

Rule of 40

JNJ22.1

RPRX32.8

EV/GP/RG

JNJ1.15

RPRXN/A

Ticker research

View JNJ research View RPRX research

Metric	JNJ Johnson & Johnson	RPRX Royalty Pharma PLC
Market & Valuation
Market Cap	$599.13B	$32.57B
Enterprise Value	$599.13B	$40.72B
Price	$248.61	$56.57
P/E Ratio	36.04x	38.65x
P/S Ratio	6.03x	12.84x
EV/Sales	6.03x	16.06x
EV/EBITDA	23.12x	25.19x
P/B Ratio	7.41x	4.79x
P/FCF Ratio	42.10x	56.41x
EV/FCF	42.10x	70.52x
PEG Ratio	3.44x	3.89x
Forward P/E (NTM)	20.15x	11.88x
Forward P/S (NTM)	5.60x	9.72x
Revenue & Growth
Revenue (TTM)	$99.34B	$2.54B
Revenue Growth (YoY)	7.8%	10.0%
Forward Rev Growth	7.3%	5.2%
Profitability
Gross Margin (TTM)	67.7%	0.0%
Operating Margin (TTM)	25.7%	59.6%
EBITDA Margin (TTM)	26.1%	62.3%
Net Margin (TTM)	16.2%	32.1%
FCF Margin (TTM)	14.3%	22.8%
Net Income (TTM)	$16.10B	$815M
FCF (TTM)	$14.23B	$578M
EPS (TTM)	$6.90	$1.46
ROE (TTM)	25.7%	12.3%
ROA (TTM)	10.6%	4.2%
ROIC (TTM)	16.0%	5.2%
Financial Health
Cash	$0	$812M
Debt	$0	$8.96B
Net Cash/Debt	$0	$-8.15B
Current Ratio (TTM)	1.09x	2.80x
Quick Ratio (TTM)	0.73x	2.80x
Debt/Equity (TTM)	0.58x	1.31x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.20	0.39
52W Performance	30.4%	57.1%
YTD Performance	19.9%	45.6%
% from 52W High	-11.5%	-12.1%
% from 52W Low	34.6%	60.6%
Efficiency & Yields
Asset Turnover (TTM)	0.49x	0.13x
FCF Yield (TTM)	2.4%	1.8%
Earnings Yield (TTM)	2.7%	2.5%
Dividend Yield (TTM)	2.0%	1.2%
Other
Rule of 40	22.1	32.8
EV/GP/RG	1.15	N/A
Ticker research	View JNJ research	View RPRX research